● Recruiting

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

Condition: Multiple Myeloma · Sponsor: Hoffmann-La Roche

PhasePhase 3

Planned participants380

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to assess the efficacy and safety of cevostamab in combination with pomalidomide and dexamethasone (CevosPd) versus standard of care (SOC) in participants with multiple myeloma (MM) who have received one to three prior lines of therapy and have been exposed to an anti-CD38 monoclonal antibody (mAb) and lenalidomide.

This description comes directly from the study's public registry record.

Talk to the study team

Reference Study ID Number: CO46096 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 · global-roche-genentech-trials@gene.com

Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry

Always discuss trial participation with your own doctor first.

Locations (15)

City of Hope National Medical Center	Duarte, California, United States	Recruiting
City of Hope - Lennar Foundation Cancer Center	Irvine, California, United States	Recruiting
Emory University Hospital Midtown	Atlanta, Georgia, United States	Recruiting
Novant Health Cancer Institute	Charlotte, North Carolina, United States	Recruiting
Forsythe Memorial Hospital Inc., dba Novant Health Oncology Specialists	Winston-Salem, North Carolina, United States	Recruiting
TriHealth Cancer and Blood Institute	Cincinnati, Ohio, United States	Recruiting
Nagoya City University Hospital	Aichi, Japan	Recruiting
University Hospital Kyoto Prefectural University of Medicine	Kyoto, Japan	Recruiting
The Cancer Institute Hospital of JFCR	Tokyo, Japan	Recruiting
Yamagata University Hospital	Yamagata, Japan	Recruiting
Auxilio Mutuo Cancer Center	San Juan, Puerto Rico	Recruiting
Chonnam National University Hwasun Hospital	Jeollanam-do, South Korea	Recruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07555938